When was MindMed founded?

MindMed was founded in 2019 and raised its 1st funding round within a year of its incorporation.

Where is MindMed located?

MindMed is headquartered in New York City, United States.

Who is the current CEO of MindMed?

Stephen L Hurst of MindMed. They have also founded 1 company.

How many employees does MindMed have?

As of May 31, 2026, the latest employee count at MindMed is 30.

Is MindMed a funded company?

MindMed is a funded company, having raised an undisclosed amount across 9 funding rounds to date. The company's 1st funding round was a $***** Post IPO round, raised on Nov 25, 2019.

When was the latest funding round of MindMed?

MindMed's latest funding was a $***** Post IPO round on Mar 11, 2024, with participation from 0 investor.

Where does MindMed rank among its competitors?

MindMed ranks 4th amongst 30 active competitors, of which 10 are funded. It stands 7th in terms of total funding among its competitors. The most recent competitor to raise funding was Gilgamesh, which secured $2.25M in Mar, 2026.

Who are the top competitors of MindMed?

MindMed's top competitors include COMPASS Pathways, Delix Therapeutics and Gilgamesh. Among them, Gilgamesh secured the most recent funding round in March, 2026.

MindMed - 2026 Company Profile, Team, Funding, Competitors & Financials

MindMed is a public company based in New York City (United States), founded in 2019 by Stephen L Hurst and JR Rahn. It operates as a Developer of psychedelic-based therapies for brain health disorders. MindMed has raised an undisclosed amount in funding. The company has 30 active competitors, including 10 funded and 14 that have exited. Its top competitors include companies like COMPASS Pathways, Delix Therapeutics and Gilgamesh.

Company Details

Developer of psychedelic-based therapies for brain health disorders. It develops product candidates to treat conditions such as generalized anxiety disorder, major depressive disorder, and autism spectrum disorder. The company utilizes rigorous scientific methods and focuses on addressing unmet patient needs in these therapeutic areas. Research and development efforts encompass diverse therapeutic areas and mechanisms of action.

Website: mindmed.co
Social

Key Metrics

Founded Year

2019

Location

New York City, United States

Stage

Public

Latest Funding Round

Post IPO, Mar 11, 2024, $*****

Investors

TR Ventures & 9 more

Ranked

4^th among 30 active competitors

Employee Count

30 as on May 31, 2026

Investment & Acquisitions

HealthMode

Similar Companies

COMPASS Pathways & 36 more

Exit Details

Public

View MindMed's full profile

MindMed is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
MIND MEDICINE (MINDMED) INC. CIN: 1813814 , United States, Active		-	74 (As on Dec 31, 2024)	-

MindMed got listed on Apr 27, 2021.

Click here to take a look at MindMed's IPO in detail

MindMed has raised funding over 9 rounds. Its first funding round was on Nov 25, 2019. MindMed has 10 institutional investors.

Here is the list of recent funding rounds of MindMed:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 11, 2024	6340654	Post IPO	1158025	2369156	2985453	7231335
Aug 11, 2023	8907487	Post IPO	3974268	3816862	1478582	4831890
Mar 08, 2021	5799504	Post IPO	1669671	2664908	1590373	5411455

Access funding benchmarks and valuations. Sign up today!

View details of MindMed's funding rounds and investors

The founders of MindMed are Stephen L Hurst and JR Rahn. Stephen L Hurst is the CEO of MindMed.

Here are the details of MindMed's key team members:

Stephen L Hurst: Co-Founder & CEO of MindMed.
JR Rahn: Co-Founder of MindMed.
Contact Info: 1 email address

View details of MindMed's Founder profiles and Board Members

MindMed's employee count trend

MindMed has 30 employees as of May 26. Here is MindMed's employee count trend over the years:

Uncover MindMed's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of MindMed include COMPASS Pathways, Delix Therapeutics and Gilgamesh. Here is the list of Top 10 competitors of MindMed, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	COMPASS Pathways 2016, London (United Kingdom), Public	Developer of therapies for treating mental disorders	$109M	Founders Fund, Perceptive Advisors & 20 others	67/100
2nd	Delix Therapeutics 2019, Menlo Park (United States), Series A	Developer of therapeutic solutions for the treatment of multiple neurological disorders	$100M	RA Capital Management, Artis Ventures & 22 others	61/100
3rd	Gilgamesh 2019, New York City (United States), Series B	Developer of drugs for neuropsychiatric conditions	$152M	Prime Movers Lab, Satori Capital & 18 others	59/100
4th	MindMed 2019, New York City (United States), Public	Developer of psychedelic-based therapies for brain health disorders	-	TR Ventures, K2 HealthVentures & 8 others	58/100
5th	Cybin 2002, Toronto (Canada), Public	Provider of psychedelic therapeutics for psychiatric disorders	-	Hightrailcapital, Subversive Capital & 10 others	56/100
6th	CB Therapeutics 2015, San Diego (United States), Series A	Provider of biosynthetic cannabinoids from sugar	$150K	EvoNexus, LYVC & 7 others	54/100
7th	Neural Therapeutics 2020, Toronto (Canada), Public	Developer of ethnobotanical drug for neurological disorder	$495K	-	48/100
8th	Tryp Therapeutics 2020, Kelowna (Canada), Public	Developer of therapeutic solutions for treating neuropsychiatric disorders & pain	-	-	48/100
9th	Psyence 1997, Toronto (Canada), Public	Developer of psychedelic therapeutics for mental health disorders	-	-	47/100
10th	Eleusis 2013, London (United Kingdom), Acquired	Developer of immunomodulatory and neuroprotective medicines	$1.47M	Palo Santo, Noetic Psychedelic Fund & 4 others	46/100